Next Science is excited to announce new indications for its flagship product, BlastX™. BlastX is an antimicrobial wound gel powered by a patented, non-toxic technology that physically disrupts the biofilm matrix. As a result, bacteria within the gel are exposed and more vulnerable to attack by antimicrobials, antibiotics, and the body’s natural immune defenses. BlastX is indicated for the management of wounds such as Stage I-IV pressure ulcers, partial- and full-thickness wounds, diabetic foot and l eg ulcers, post-surgical wounds, first and second degree burns, and grafted and donor sites.

Learn more about BlastX